Back to User profile » Dr Junying Xu

Papers published by Dr Junying Xu:


PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer

Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J

Pharmacogenomics and Personalized Medicine 2023, 16:747-758

Published Date: 9 August 2023

Total T Cell Density and Expression of T Memory Stem Cell Markers are Associated with Better Prognosis in Colon Cancer

Ding J, Wang H, Hou R, Shi Y, Fan H, Li Y, Mei J, Zhang Q, Ruan T, Xu J

International Journal of General Medicine 2023, 16:2285-2294

Published Date: 5 June 2023

GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC

Fan H, Shi Y, Wang H, Li Y, Mei J, Xu J, Liu C

International Journal of General Medicine 2023, 16:1757-1769

Published Date: 10 May 2023

The Clinical Significance of Deglycosylated PD-L1 Level Detection Using 28-8 Monoclonal Antibody in Lung Adenocarcinoma

Wang H, Gu D, Chen D, Mei J, Yang X, Ding J, Xu J, Wang M, Liu C, Hua D

International Journal of General Medicine 2022, 15:7383-7393

Published Date: 19 September 2022